Despite these elevated price points, one in eight U.S
4 Involvement of the gastrointestinal (GI) tract can also affect the esophagus, small bowel, and colon, which may impact enteral nutrition and the absorption of oral medications
Di Rocco F, Roujeau T, Pujet S, Peyre M, Zerah M
Semaglutide is a GLP-1 receptor agonist already approved separately as Ozempic, Wegovy, and Rybelsus depending on formulation and indication
Emerging Players The emerging players in the glucagon-like peptide 1 (GLP-1) analogues market include Gmax Biopharm., Sciwind Biosciences Co., Ltd., Teva Pharmaceuticals, Inc., Hikma Pharmaceuticals PLC (Hikma), Viking Therapeutics, Terns Pharmaceuticals, Inc., Altimmune, AVVA Pharmaceuticals Ltd, LEXICARE PHARMA PVT
10.1136/annrheumdis-2020-218089 60 HuY.ChenX.WangS.JingY.SuJ